Title |
Tahyna virus genetics, infectivity, and immunogenicity in mice and monkeys
|
---|---|
Published in |
Virology Journal, March 2011
|
DOI | 10.1186/1743-422x-8-135 |
Pubmed ID | |
Authors |
Richard S Bennett, Anthony K Gresko, Brian R Murphy, Stephen S Whitehead |
Abstract |
Tahyna virus (TAHV) is a human pathogen of the California encephalitis virus (CEV) serogroup (Bunyaviridae) endemic to Europe, Asia, and Africa. TAHV maintains an enzootic life cycle with several species of mosquito vectors and hares, rabbits, hedgehogs, and rodents serving as small mammal amplifying hosts. Human TAHV infection occurs in summer and early fall with symptoms of fever, headache, malaise, conjunctivitis, pharyngitis, and nausea. TAHV disease can progress to CNS involvement, although unlike related La Crosse virus (LACV), fatalities have not been reported. Human infections are frequent with neutralizing antibodies present in 60-80% of the elderly population in endemic areas. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 39 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 8 | 21% |
Student > Doctoral Student | 5 | 13% |
Student > Master | 4 | 10% |
Student > Bachelor | 3 | 8% |
Professor | 2 | 5% |
Other | 8 | 21% |
Unknown | 9 | 23% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 12 | 31% |
Biochemistry, Genetics and Molecular Biology | 5 | 13% |
Veterinary Science and Veterinary Medicine | 4 | 10% |
Medicine and Dentistry | 3 | 8% |
Immunology and Microbiology | 3 | 8% |
Other | 5 | 13% |
Unknown | 7 | 18% |